↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

136 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   1-20190   -   -   -   -   1件:
93 
 2   11c-csar   -   -   -   -   2件:
93,
94 
 3   13-15mg/kg/d ursodeoxycholic   -   -   -   -   1件:
93 
 4   18-22mg/kg/d ursodeoxycholic   -   -   -   -   1件:
93 
 5   3 mg [14c]-a4250 capsule   -   -   -   -   2件:
93,
297 
 6   6 alpha-ethylchenodeoxycholic acid (6-edca), oca, int-747   -   -   -   -   1件:
93 
 7   6-ethylchenodeoxycholic acid   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 8   6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 9   6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (oca)   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 10   6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 11   6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (oca)   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 12   6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 13   6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (oca)   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 14   6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 15   6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (oca)   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 16   A11ha02   -   -   -   -   1件:
93 
 17   A4250   -   -   -   -   2件:
93,
297 
 18   Abatacept   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 19   Apd334   -   -   -   -   4件:
93,
96,
97,
269 
 20   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 21   Baricitinib   Baricitinib   D10308   2件: JAK1, JAK2   32件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   8件:
41,
46,
49,
50,
93,
107,
265,
325 
 22   Bcd-085   -   -   -   -   2件:
93,
271 
 23   Bezafibrat   -   -   -   -   1件:
93 
 24   Bezafibrat genericon retard 400 mg   -   -   -   -   1件:
93 
 25   Bezafibrate   Bezafibrate   D01366   1件: PPARA   7件: Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   5件:
20,
93,
94,
160,
316 
 26   Bezalip   -   -   -   -   2件:
93,
94 
 27   Budenofalk 3mg   -   -   -   -   2件:
93,
97 
 28   Budesonide   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   9件:
66,
93,
94,
95,
96,
97,
98,
228,
299 
 29   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 30   Cilofexor   Cilofexor   -   -   -   2件:
93,
94 
 31   Colchicine   Colchicine   D00570   9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   3件: Gap junction, Pathogenic Escherichia coli infection, Phagosome   5件:
2,
42,
56,
93,
266 
 32   Combination antiviral therapy   -   -   -   -   1件:
93 
 33   Cr845 1.0 mg   -   -   -   -   1件:
93 
 34   Crc (a3384)   -   -   -   -   2件:
93,
297 
 35   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 36   Denosumab   Denosumab   D03684   1件: TNFSF11   7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis   7件:
46,
50,
93,
95,
96,
274,
299 
 37   E6011   -   -   -   -   3件:
46,
93,
96 
 38   Edp-305   -   -   -   -   1件:
93 
 39   Edp-305 dose 1   -   -   -   -   1件:
93 
 40   Edp-305 dose 2   -   -   -   -   1件:
93 
 41   Elafibranor   Elafibranor   D11208   1件: PPARA   7件: Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   1件:
93 
 42   Elafibranor 120 mg   Elafibranor   D11208   1件: PPARA   7件: Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   1件:
93 
 43   Elafibranor 80 mg   Elafibranor   D11208   1件: PPARA   7件: Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   1件:
93 
 44   Emtricitabine   Emtricitabine   D01199   -   -   4件:
25,
93,
265,
325 
 45   Emtricitabine (ftc)/tenofovir disoproxil (tdf)   Tenofovir disoproxil   D01982   -   -   1件:
93 
 46   Ezetimibe   Ezetimibe   D01966   1件: NPC1L1   1件: Fat digestion and absorption   4件:
49,
79,
93,
260 
 47   Ezetrol   Ezetimibe   D01966   1件: NPC1L1   1件: Fat digestion and absorption   2件:
93,
260 
 48   Fenofibrate   Fenofibrate   D00565   1件: PPARA   7件: Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   5件:
8,
79,
93,
94,
265 
 49   Fenofibrate (insoluble drug delivery-micro particle fenofibrate (idd-p)   Fenofibrate   D00565   1件: PPARA   7件: Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   1件:
93 
 50   Ffp104   -   -   -   -   2件:
93,
96 
 51   Fully human monoclonal antibody directed against cxcl10   -   -   -   -   1件:
93 
 52   Fuzhenghuayu   -   -   -   -   1件:
93 
 53   Gft505   -   -   -   -   1件:
93 
 54   Gkt137831   -   -   -   -   2件:
85,
93 
 55   Gsk2330672   Gsk2330672   -   -   -   1件:
93 
 56   High protein high fiber diet   -   -   -   -   2件:
93,
95 
 57   Int-747   -   -   -   -   1件:
93 
 58   Int-747, oca   -   -   -   -   2件:
93,
94 
 59   Liver biopsy   -   -   -   -   1件:
93 
 60   Lum001   -   -   -   -   3件:
93,
94,
297 
 61   Mabthera®   -   -   -   -   6件:
13,
35,
43,
44,
46,
93 
 62   Magnesium   Magnesium   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 63   Mbx 8025   -   -   -   -   1件:
93 
 64   Mbx-8025   -   -   -   -   2件:
79,
93 
 65   Mbx-8025 10 mg capsule   -   -   -   -   1件:
93 
 66   Mbx-8025 2 mg capsule   -   -   -   -   1件:
93 
 67   Mbx-8025 5 mg capsule   -   -   -   -   1件:
93 
 68   Mesenchymal stem cell   -   -   -   -   2件:
2,
93 
 69   Methionine   Methionine   D00019, D04983   -   -   6件:
34,
75,
84,
93,
229,
300 
 70   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 71   Minodronic acid   Minodronic acid   -   -   -   4件:
6,
46,
93,
95 
 72   Modafinil   Modafinil   D01832   -   -   4件:
6,
13,
49,
93 
 73   Moexipril   Moexipril   D00623, D08225   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   1件:
93 
 74   Ngm282   -   -   -   -   2件:
93,
94 
 75   Ni-0801   -   -   -   -   1件:
93 
 76   Non-myeloablative hematopoietic stem cell transplantation   -   -   -   -   1件:
93 
 77   Obeticholic acid   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   3件:
93,
265,
296 
 78   Obeticholic acid (oca)   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 79   Oca (int-747)   -   -   -   -   1件:
93 
 80   Ocaliva   Obeticholic acid   D09360   1件: NR1H4   1件: Bile secretion   1件:
93 
 81   Op-724   -   -   -   -   1件:
93 
 82   Part 1: ljn452   -   -   -   -   1件:
93 
 83   Part 2: ljn452 dose level 1   -   -   -   -   1件:
93 
 84   Part 2: ljn452 dose level 2   -   -   -   -   1件:
93 
 85   Pentoxifylline   Pentoxifylline   D00501   -   -   10件:
26,
56,
84,
93,
96,
113,
220,
222,
296,
298 
 86   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   10件:
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 87   Pyridoxine   Pyridoxine   D02179, D08454   -   -   2件:
93,
145 
 88   Pyridoxine 10mg   Pyridoxine   D02179, D08454   -   -   1件:
93 
 89   Pyridoxine 10mg bp   Pyridoxine   D02179, D08454   -   -   1件:
93 
 90   Questran   Cholestyramine   -   -   -   3件:
93,
254,
297 
 91   Raltegravir   Raltegravir   D06676   -   -   4件:
13,
26,
93,
265 
 92   Risedronic acid   Risedronic acid   D00942, D03234, D08484   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   3件:
93,
95,
274 
 93   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 94   S-adenosyl-l-methionine   Methionine   D00019, D04983   -   -   1件:
93 
 95   S-adenosyl-methionine (same) capsules   Methionine   D00019, D04983   -   -   1件:
93 
 96   Same   Ademetionine   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 97   Saroglitazar   Saroglitazar   -   -   -   1件:
93 
 98   Saroglitazar magnesium 2 mg   Saroglitazar   -   -   -   1件:
93 
 99   Saroglitazar magnesium 4 mg   Saroglitazar   -   -   -   1件:
93 
 100   Seladelpar   -   -   -   -   2件:
93,
94 
 101   Seladelpar 10 mg   -   -   -   -   1件:
93 
 102   Seladelpar 10 mg capsule   -   -   -   -   1件:
93 
 103   Seladelpar 2 mg capsule   -   -   -   -   1件:
93 
 104   Seladelpar 5 mg capsule   -   -   -   -   1件:
93 
 105   Seladelpar 5-10 mg   -   -   -   -   1件:
93 
 106   Sortis   -   -   -   -   1件:
93 
 107   Sortis 10 mg   -   -   -   -   1件:
93 
 108   Sublimated mare milk   -   -   -   -   1件:
93 
 109   Tauroursodeoxycholic acid   Tauroursodeoxycholic acid   -   -   -   4件:
2,
13,
93,
299 
 110   Tauroursodeoxycholic acid capsules   Tauroursodeoxycholic acid   -   -   -   1件:
93 
 111   Tenofovir   Tenofovir   D06074   -   -   5件:
2,
25,
93,
265,
325 
 112   Tenofovir disoproxil   Tenofovir disoproxil   D01982   -   -   2件:
93,
265 
 113   Tetrathiomolybdate   Tetrathiomolybdate   -   -   -   3件:
85,
93,
171 
 114   Tigecycline   Tigecycline   D01079   -   -   1件:
93 
 115   Truvada and kaletra   -   -   -   -   1件:
93 
 116   Udca   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   3件:
93,
94,
97 
 117   Udca (ursodeoxycholic acid)   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   1件:
93 
 118   Udca combined probiotics   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   1件:
93 
 119   Ursodeoxycholic acid   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   8件:
6,
67,
84,
93,
94,
95,
96,
97 
 120   Ursodeoxycholic acid (urso)   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   1件:
93 
 121   Ursodeoxycholic acid 300mg capsule   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   1件:
93 
 122   Ursodeoxycholic acid 300mg tablet   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   1件:
93 
 123   Ursodeoxycholic acid capsules   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   1件:
93 
 124   Ursodeoxycholic acid combination of immunosuppressive agents   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   2件:
93,
95 
 125   Ursodeoxycholsäure   -   -   -   -   1件:
93 
 126   Ursodiol   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   6件:
8,
20,
93,
97,
234,
299 
 127   Ursofalk   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   4件:
93,
94,
96,
97 
 128   Ursofalk® 500 mg film-coated tablets   -   -   -   -   1件:
93 
 129   Ursofalk® 500 mg filmtabletten   -   -   -   -   1件:
93 
 130   Ursofalk® capsules   -   -   -   -   1件:
93 
 131   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 
 132   Ustekinumab 180 mg   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   1件:
93 
 133   Ustekinumab 45 mg   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   1件:
93 
 134   Ustekinumab 90 mg   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   3件:
50,
93,
96 
 135   Vitamin d   Vitamin d   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 136   Zoledronic acid   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   9件:
6,
13,
46,
93,
95,
96,
274,
299,
333 

先頭へ